Open AccessInhalation of molecular hydrogen increases breath acetone excretion during submaximal exercise: a randomized, single-blinded, placebo-controlled study
Author(s) -
Amane Hori,
Masatoshi Ichihara,
Hayata Kimura,
Haruhiko Ogata,
Takaharu Kondo,
Nigishi Hotta
Publication year - 2020
Publication title -
medical gas research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.52
H-Index - 24
ISSN - 2045-9912
DOI - 10.4103/2045-9912.296038
Subject(s) - placebo , inhalation , medicine , anesthesia , randomized controlled trial , blinded study , physical therapy , pathology , alternative medicine
Aerobic exercise is widely accepted as a beneficial option for reducing fat in humans. Recently, it has been suggested that molecular hydrogen (H 2 ) augments mitochondrial oxidative phosphorylation. Therefore, the hypothesis that inhaling H 2 could facilitate lipid metabolism during aerobic exercise was investigated in the current study by measuring the breath acetone levels, which could be used as non-invasive indicators of lipid metabolism. This study aimed to investigate the effect of inhaling H 2 on breath acetone output during submaximal exercise using a randomized, single-blinded, placebo-controlled, and cross-over experimental design. After taking a 20-minute baseline measurement, breath acetone levels were measured in ten male subjects who performed a 60% peak oxygen uptake-intensity cycling exercise for 20 minutes while inhaling either 1% H 2 or a control gas. In another experiment, six male subjects remained in a sitting position for 45 minutes while inhaling either 1% H 2 or a control gas. H 2 significantly augmented breath acetone and enhanced oxygen uptake during exercise (P < 0.01). However, it did not significantly change oxidative stress or antioxidant activity responses to exercise, nor did it significantly alter the breath acetone or oxygen uptake during prolonged resting states. These results suggest that inhaling H 2 gas promotes an exercise-induced increase in hepatic lipid metabolism. The study was approved by the Ethical Committee of Chubu University, Japan (approved No. 260086-2) on March 29, 2018.